LGE-899

CAS No. 1221722-10-6

LGE-899( LGE 899 | LGE899 | Sonidegib metabolite M48 )

Catalog No. M27319 CAS No. 1221722-10-6

LGE-899 is a main metabolite of Sonidegib which is an inhibitor of the hedgehog pathway.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 50 Get Quote
50MG 68 Get Quote
100MG 88 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LGE-899
  • Note
    Research use only, not for human use.
  • Brief Description
    LGE-899 is a main metabolite of Sonidegib which is an inhibitor of the hedgehog pathway.
  • Description
    LGE-899 is a main metabolite of Sonidegib which is an inhibitor of the hedgehog pathway. The Tmax of LGE-899(60 h) is much longer than Sonidegib.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    LGE 899 | LGE899 | Sonidegib metabolite M48
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    DPP-4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1221722-10-6
  • Formula Weight
    296.245
  • Molecular Formula
    C15H11F3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1c(cccc1-c1ccc(OC(F)(F)F)cc1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jeffrey B. Harborne. Flavonoid patterns and phytogeography: the genus Rhododendron section Vireya.Phytochemistry, 1986, 25(7):1641-1643.
molnova catalog
related products
  • Atosiban acetate

    Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labor. Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane.

  • 6-Methoxyflavanone

    6-Methoxyflavanone (6-MeOF) is A positive allosteric modulator of the GABA response of human recombinant GABA A receptor, with antianxiety and anti-inflammatory activity, and can be used to reduce cisplatin induced neuropathic pain.

  • Mirificin

    Puerarin has been investigated for the treatment of Alcohol Abuse.